Keywords
HPLC-DAD
an active pharmaceutical ingredient
Abstract
Derivatives of 1,2,4-triazole are actively researched by scientists and synthetic pharmacologists. The last studies have shown that potassium 2-((4-amino-5-(morpholinomethyl)-4H-1,2,4-triazol-3-yl)thio)acetate with low toxicity series exhibits antioxidant and hepatoprotective properties. Therefore, the purpose of this work was to develop a method for determining the API in the potassium 2-((4-amino-5-(morpholinomethyl)-4H-1,2,4-triazol-3-yl)thio)acetate substance using the method of high-performance liquid chromatography with diode array detection (HPLC-DAD). As a result of this work, it is shown that the developed method is specific and meets the requirements of linearity, accuracy and precision. The results of determining the contents of the API in real samples indicate that the method can be proposed to control the quality of the potassium 2-((4-amino-5-(morpholinomethyl)-4H-1,2,4-triazol-3-yl)thio)acetate substance.References
1. Blumenthal GM, Goldberg KB, Pazdur R. Drug development, trial design, and endpoints in oncology: adapting to rapidly changing science. Clinical Pharmacology & Therapeutics. 2017;101:572-4.
2. Dimitrios Z, Pridgen CS, Vincenzo L. Process development and robust control of physical attributes of an amorphous drug substance. Journal of Pharmaceutical Sciences. 2018;107:217-30.
3. Sandeep S, Vohora D. Drug discovery and development: An overview. Pharmaceutical Medicine and Translational Clinical Research. 2018;19:19-32.
4. Bulut N, Kocyigit UM, Gecibesler IH, Dastan T, Karci H, Taslimi P et al. Synthesis of some novel pyridine compounds containing bis 1,2,4-triazole/thiosemicarbazide moiety and investigation of their antioxidant properties, carbonic anhydrase, and acetylcholinesterase enzymes inhibition profiles. Journal of Biochemical and Molecular Toxicology. 2018;32: 1-10.
5. Kumar R, Shahar Yar M, Chaturvedi S, Srivastava A. Triazole as pharmaceuticals potentials. Int. J. pharm. Tech. Res. 2013;5:1844-69.
6. El-Gazzar YI, Georgey HH, El-Messery SM, Ewida HA, Hassan GS, Raafat MM, et al. Synthesis, biological evaluation and molecular modeling study of new (1,2,4-triazole or 1,3,4-thiadiazole)-methylthio-derivatives of quinazolin-4(3H)-one as DHFR inhibitors. Bioorganic Chemistry. 2017; 72: 282-92.
7. Shcherbyna RO, Danilchenko DM, Parchenko VV, Panasenko OI, Knysh EH, Hromyh NA, et al. Studying of 2-((5-R-4-R1-4H-1,2,4-triazole-3-yl)thio)acetic acid salts influence on growth and progress of blackberries (KIOWA Variety) propagules. Res. J. Pharm., Biol. Chem. Sci. 2017;8: 975-9.
8. Singala P, Talpara P. Synthesis of new 1,2,4-triazole derivatives and their antimicrobial screening. International Journal of Scientific Research in Science, Engineering and Technology. 2017;3:1009-12.
9. Shcherbyna RО, Samura ТО, Kyrychko BP, Zvenihorodska ТV, Hyrenko IV. The research of ammonium 2-((4-amino-5-(morpholinomethyl)-4H-1,2,4-triazole-3-yl)thio)acetate (PKR-177) influence on biochemical indices in rats blood under hepatitis initiated by tetrachloride methane. Zaporozhye Medical Journal. 2017; 19:819-22.
10. Shcherbyna RО, Panasenko OI, Knysh YG, Fotina HA, Vashchyk YV, Fotina TI. The study of antimicrobial activity of 2-((4-R-3-(morpholinomethylene)-4H-1,2,4-triazole-5-yl)thio)acetic acid salts. Zaporozhye Medical Journal. 2016;4:97-0.
11. Shcherbyna RO, Panasenko OI, Knysh YeH. The studying of antioxidant activity of salts 2-((4-R-3-(morpholinomethylen)-4H-1,2,4-triazole-5-yl)thio)acetic acids. Ukraïns’kij Bìofarmacevtičnij Žurnal. 2016;42: 37-0.
12. Anderson J, Gerlin M, Sversut R, Oliveira L, Singh A, Amaral M et al. Development and validation of an isocratic HPLC method for simultaneous determination of quaternary mixtures of antihypertensive drugs in pharmaceutical formulations. Acta Chromatographica. 2017;29:95-10.
13. Baker M, El-Kafrawy D, Mahrous M, Belal T. Validated stability-indicating HPLC-DAD method for determination of the recently approved hepatitis C antiviral agent daclatasvir. Annales Pharmaceutiques Françaises. 2017;75:176-4.
14. Pavlović D, Babić S, Horvat A, Kaštelan-Macan M. Sample preparation in analysis of pharmaceuticals. TrAC Trends in Analytical Chemistry. 2007;26:1062-5.
15. Shcherbyna RO. Synthesis, physical and chemical properties of 2-((4-R-3-(morfolinomethylen)-4H-1,2,4-triazole-5-yl)thio)acetic acid salts. Current issues in pharmacy and medicine: science and practice. 2017;10: 4-8.
16. State Pharmacopoeia of Ukraine. 1st ed. Kharkiv: DP “Naukovo-ekspertnii farmakopeinii tsentr”;2001:538.
17. State Pharmacopoeia of Ukraine. Supplement 1. 2nd ed. Kharkiv: RIREKH; 2004: 494.
18. European pharmacopoeia. Strasbourg: Council of Europe; 2016
19. Direct injection electrospray mass spectrometry using Agilent 1100 Series LC-MS [Internet]. Haverford; 2018 [cited 29 March 2018]. Available from: https://www.haverford.edu/sites/default/files/Department/Chemistry/Agilent%20Direct%20Inject.pdf
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 Unported License.
Copyright (c) 2019 Autors